ArticleClinical epigenetics2018

KAT3B-p300 and H3AcK18/H3AcK14 levels are prognostic markers for kidney ccRCC tumor aggressiveness and target of KAT inhibitor CPTH2.

Elisa Cocco et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.